Antiviral Activity of Dolutegravir in Subjects with Failure on an Integrase Inhibitor-Based Regimen: Week 24 Phase 3 Results from VIKING-3 (2)

Conference Reports for NATAP

11th International Congress
on Drug Therapy in HIV Infection
11-15 November 2012 Glasgow, UK


Antiviral Activity of Dolutegravir in Subjects with Failure on an Integrase Inhibitor-Based Regimen: Week 24 Phase 3 Results from VIKING-3 (2) Oral

	Reported by Jules Levin Glasgow 2012 Nov 11-15 Oral presentation in Glasgow